ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
IBRX on Nasdaq
CUSIP
45256X103
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1.08B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
150M
Holdings value
$368M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
257
Number of buys
136
Number of sells
-79
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cambridge Equities, LP 68.9% $1.83B 744M Patrick Soon-Shiong Nov 10, 2025

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 150M $368M +$61.4M $2.46 257
2025 Q2 124M $328M +$117M $2.64 236
2025 Q1 79.5M $239M -$5.45M $3.01 205
2024 Q4 82.6M $212M +$33.8M $2.56 193
2024 Q3 68.6M $255M +$21.7M $3.72 174
2024 Q2 61.6M $390M -$21.4M $6.32 191
2024 Q1 66M $354M +$50.3M $5.37 159
2023 Q4 57.3M $288M +$54.7M $5.02 142
2023 Q3 49.8M $84M +$17.5M $1.69 131
2023 Q2 38.8M $108M -$8.6M $2.78 111
2023 Q1 46.2M $84M -$34.9M $1.82 143
2022 Q4 50M $253M +$54M $5.07 134
2022 Q3 39.5M $196M +$32.5M $4.97 117
2022 Q2 33.1M $123M -$11.2M $3.72 125
2022 Q1 35.6M $200M +$5.89M $5.61 135
2021 Q4 34.4M $209M +$13.2M $6.08 127
2021 Q3 31.9M $311M +$41.9M $9.74 118
2021 Q2 27.3M $390M +$156M $14.28 117
2021 Q1 15.9M $378M +$377M $23.74 113
2020 Q4 100 $1K $0 $10.00 1
2020 Q3 100 $1K $0 $10.00 1
2020 Q2 100 $1K $0 $10.00 1
2020 Q1 100 $1K $0 $10.00 1
2019 Q4 100 $1K $0 $10.00 1
2019 Q3 100 $1K $0 $10.00 1
2019 Q2 100 $1K $0 $10.00 1
2019 Q1 100 $1K $0 $10.00 1